BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16447780)

  • 1. [Death of motor neurons and molecular change of glutamate receptors in ALS].
    Shin K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):982-4. PubMed ID: 16447780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS.
    Kawahara Y; Kwak S; Sun H; Ito K; Hashida H; Aizawa H; Jeong SY; Kanazawa I
    J Neurochem; 2003 May; 85(3):680-9. PubMed ID: 12694394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate receptors: RNA editing and death of motor neurons.
    Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
    Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA.
    Kawahara Y; Sun H; Ito K; Hideyama T; Aoki M; Sobue G; Tsuji S; Kwak S
    Neurosci Res; 2006 Jan; 54(1):11-4. PubMed ID: 16225946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
    Kawahara Y; Kwak S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
    Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ALS and excitatory amino acid].
    Aizawa H; Kwak S
    Brain Nerve; 2007 Oct; 59(10):1117-27. PubMed ID: 17969352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis.
    Takuma H; Kwak S; Yoshizawa T; Kanazawa I
    Ann Neurol; 1999 Dec; 46(6):806-15. PubMed ID: 10589532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the study of AMPA receptors].
    Suzuki T; Tsuzuki K; Kameyama K; Kwak S
    Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):515-26. PubMed ID: 14639006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edited GluR2, a gatekeeper for motor neurone survival?
    Buckingham SD; Kwak S; Jones AK; Blackshaw SE; Sattelle DB
    Bioessays; 2008 Nov; 30(11-12):1185-92. PubMed ID: 18937367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability.
    Vandenberghe W; Robberecht W; Brorson JR
    J Neurosci; 2000 Jan; 20(1):123-32. PubMed ID: 10627588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of AMPA receptors and VEGF in ALS.
    Van Damme P
    Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.
    Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):605-12. PubMed ID: 16042312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of neurons to excitotoxic levels of glutamate induces cleavage of the RNA editing enzyme, adenosine deaminase acting on RNA 2, and loss of GLUR2 editing.
    Mahajan SS; Thai KH; Chen K; Ziff E
    Neuroscience; 2011 Aug; 189():305-15. PubMed ID: 21620933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.